Список литературы к Главe 2

1. Hallek M., Cheson B.D., Catovsky D., Caligaris­Cappio F., Dighiero G., Dohner H. et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL // Blood. 2018. Vol. 131, N 25. P. 2745–2760.

2. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J. et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis // Cancer. 1981. Vol. 48, N 1. P. 198–206.

3. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia // Blood. 1975. Vol. 46, N 2. P. 219–234.

4. Baliakas P., Mattsson M., Stamatopoulos K., Rosenquist R. Prognostic indices in chronic lymphocytic leukaemia: where do we stand how do we proceed? // J. Intern. Med. 2016. Vol. 279, N 4. P. 347–357.

5. Gunnarsson R., Mansouri L., Rosenquist R. Exploring the genetic landscape in chronic lymphocytic leukemia using high­resolution technologies // Leuk. Lymphoma. 2013. Vol. 54, N 8. P. 1583–1590.

6. Caspersson T., Zech L., Johansson C., Modest E.J. Identification of human chromosomes by DNA­binding fluorescent agents // Chromosoma. 1970. Vol. 30, N 2. P. 215–227.

7. Goodwin S., McPherson J.D., McCombie W.R. Coming of age: ten years of next­generation sequencing technologies // Nat. Rev. Genet. 2016. Vol. 17, N 6. P. 333–351.

8. Puente X.S., Pinyol M., Quesada V., Conde L., Ordonez G.R., Villamor N. et al. Whole­genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia // Nature. 2011. Vol. 475, N 7354. P. 101–105.

9. Quesada V., Conde L., Villamor N., Ordonez G.R., Jares P., Bassaganyas L. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia // Nat. Genet. 2011. Vol. 44, N 1. P. 47–52.

10. Wang L., Lawrence M.S., Wan Y., Stojanov P., Sougnez C., Stevenson K. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia // N. Engl. J. Med. 2011. Vol. 365, N 26. P. 2497–2506.

11. Fabbri G., Rasi S., Rossi D., Trifonov V., Khiabanian H., Ma J. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation // J. Exp. Med. 2011. Vol. 208, N 7. P. 1389–1401.

12. Zech L., Mellstedt H. Chromosome 13 – a new marker for B­cell chronic lymphocytic leukemia // Hereditas. 1988. Vol. 108, N 1. P. 77–84.

13. Gahrton G., Robert K.H., Friberg K., Zech L., Bird A.G. Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B­cell­mitogen stimulation // Blood. 1980. Vol. 56, N 4. P. 640–647.

14. Gahrton G., Robert K.H., Friberg K., Zech L., Bird A.G. Extra chromosome 12 in chronic lymphocytic leukaemia // Lancet. 1980. Vol. 1, N 8160. P. 146–147.

15. Hurley J.N., Fu S.M., Kunkel H.G., Chaganti R.S., German J. Chromosome abnormalities of leukaemic B lymphocytes in chronic lymphocytic leukaemia // Nature. 1980. Vol. 283, N 5742. P. 76–78.

16. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J. et al. Prognostic subgroups in B­cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities // N. Engl. J. Med. 1990. Vol. 323, N 11. P. 720–724.

17. Haferlach C., Bacher U. Cytogenetic methods in chronic lymphocytic leukemia // Methods Mol. Biol. 2011. Vol. 730. P. 119–130.

18. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L. et al. Genomic aberrations and survival in chronic lymphocytic leukemia // N. Engl. J. Med. 2000. Vol. 343, N 26. P. 1910–1916.

19. Gunnarsson R., Mansouri L., Isaksson A., Goransson H., Cahill N., Jansson M. et al. Array­based genomic screening at diagnosis and during follow­up in chronic lymphocytic leukemia // Haematologica. 2011. Vol. 96, N 8. P. 1161–1169.

20. Haferlach C., Dicker F., Schnittger S., Kern W., Haferlach T. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping // Leukemia. 2007. Vol. 21, N 12. P. 2442–2451.

22. Mabuchi H., Fujii H., Calin G., Alder H., Negrini M., Rassenti L. et al. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candid ate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B­cell chronic lymphocytic leukemia // Cancer Res. 2001. Vol. 61, N 7. P. 2870–2877.

23. Migliazza A., Bosch F., Komatsu H., Cayanis E., Martinotti S., Toniato E. et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B­cell chronic lymphocytic leukemia // Blood. 2001. Vol. 97, N 7. P. 2098–2104.

24. Hammarsund M., Corcoran M.M., Wilson W., Zhu C., Einhorn S., Sangfelt O. et al. Characterization of a novel B­CLL candidate gene­DLEU7­located in the 13q14 tumor suppressor locus // FEBS Lett. 2004. Vol. 556, N 1–3. P. 75–80.

25. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E. et al. Frequent deletions and down­regulation of micro­RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia // Proc. Natl Acad. Sci. USA. 2002. Vol. 99, N 24. P. 15 524–15 529.

26. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M. et al. miR­15 and miR­16 induce apoptosis by targeting BCL2 // Proc. Natl Acad. Sci. USA. 2005. Vol. 102, N 39. P. 13 944–13 949.

27. Klein U., Lia M., Crespo M., Siegel R., Shen Q., Mo T. et al. The DLEU2/miR­15a/16­1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia // Cancer Cell. 2010. Vol. 17, N 1. P. 28–40.

28. Stilgenbauer S., Winkler D., Ott G., Schaffner C., Leupolt E., Bentz M. et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma // Blood. 1999. Vol. 94, N 9. P. 3262–3264.